The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth. [electronic resource]
Producer: 20051213Description: 623-42 p. digitalISSN:- 1744-7631
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Basic Helix-Loop-Helix Leucine Zipper Transcription Factors -- physiology
- Cell Cycle -- drug effects
- Cell Differentiation -- drug effects
- Cell Division -- drug effects
- Coronary Restenosis -- prevention & control
- Diabetes Mellitus -- drug therapy
- Drug Design
- Gene Expression Regulation, Neoplastic -- drug effects
- Genes, myc
- Genetic Therapy
- Glucose -- metabolism
- Growth Substances -- physiology
- Humans
- Hypoglycemic Agents -- adverse effects
- Insulin -- metabolism
- Insulin Secretion
- Islets of Langerhans -- metabolism
- Mice
- Mice, Transgenic
- Models, Biological
- Neoplasms -- drug therapy
- Oligonucleotides, Antisense -- therapeutic use
- Proto-Oncogene Mas
- Proto-Oncogene Proteins c-myc -- antagonists & inhibitors
- RNA, Small Interfering -- therapeutic use
- Repressor Proteins -- physiology
- Transcription, Genetic
- Tumor Escape
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.